newsfilter
← Latest News
Business Wire·

NeoGenomics Reports Third Quarter 2025 Results

Third quarter total revenue increased 12% YoY to $188 million Clinical revenue grew 18%, or 15% excluding the Pathline acquisition NGS revenue increased 24% YoY and now accounts for nearly one-third of clinical